Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹74 Cr
Revenue (TTM)
₹151 Cr
Net Profit (TTM)
₹5 Cr
ROE
5.2 %
ROCE
6.9 %
P/E Ratio
15.1
P/B Ratio
0.8
Industry P/E
25.15
EV/EBITDA
9.6
Div. Yield
0 %
Debt to Equity
0
Book Value
₹5.3
EPS
₹0.3
Face value
2
Shares outstanding
172,243,598
CFO
₹-5.48 Cr
EBITDA
₹17.01 Cr
Net Profit
₹9.60 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Ajooni Biotech
| -0.5 | -13.0 | 2.1 | -31.9 | 7.7 | -2.9 | -- |
|
BSE FMCG
| -14.5 | -10.3 | -13.8 | -9.5 | 2.2 | 7.0 | 8.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Ajooni Biotech
| -47.1 | 33.5 | 2.4 | -50.5 | 164.6 | 251.6 | -65.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE FMCG
| -2.1 | 1.5 | 27.3 | 16.6 | 9.3 | 10.5 | -3.6 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Ajooni Biotech
|
4.3 | 73.9 | 151.0 | 4.9 | 3.0 | 5.5 | 15.1 | 0.8 |
| 176.3 | 22,926.3 | 71,495.5 | 897.7 | 2.3 | 9.9 | 24.4 | 2.3 | |
| 610.1 | 15,350.1 | 2,886.6 | 238.3 | 10.5 | 17.3 | 62.3 | 9.8 | |
| 573.9 | 11,033.0 | 10,033.7 | 366.3 | 6.4 | 22.1 | 25.1 | 5.8 | |
| 990.6 | 22,113.3 | 9,624.4 | 348.3 | 6.4 | 19.6 | 63.5 | 11.7 | |
| 190.4 | 609.3 | 1,663.1 | 122.6 | 9.2 | 37.8 | 5 | 1.7 | |
| 31.8 | 120.5 | 73.7 | 3.8 | 5.9 | 6.7 | 31.4 | 2.0 | |
| 14.7 | 7.7 | 10.1 | 1.0 | 1.3 | 9.1 | 7.4 | 0.5 | |
| 25.5 | 15.5 | 2.2 | 0.6 | 24.3 | 4 | 25.8 | 1.0 | |
| 22.8 | 9.3 | 0.0 | 0.1 | -- | 2.5 | 72.4 | 1.5 |
No Review & Analysis are available.
Ajooni Biotech Limited manufactures and sells cattle feed in India. Its portfolio includes cattle feed chips, camel feed, cotton oil cakes, mustard oil cakes, and feed supplements. Ajooni Biotech Limited was incorporated in 2010 and is based in... Mohali, India. Read more
Incorporated
2010
Chairman
--
Managing Director
Jasjot Singh
Headquarters
Mohali, Punjab
Website
Looking for more details about Ajooni Biotech Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Announcements
View Announcements
The share price of Ajooni Biotech Ltd is ₹4.29 (NSE) as of 19-Mar-2026 IST. Ajooni Biotech Ltd has given a return of 7.65% in the last 3 years.
The P/E ratio of Ajooni Biotech Ltd is 15.06 times as on 19-Mar-2026, a 40 discount to its peers’ median range of 25.15 times.
The P/B ratio of Ajooni Biotech Ltd is 0.82 times as on 19-Mar-2026, a 46 discount to its peers’ median range of 1.51 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
28.60
|
1.10
|
|
2024
|
21.09
|
1.07
|
|
2023
|
27.12
|
0.73
|
|
2022
|
9.98
|
3.20
|
|
2021
|
14.38
|
1.52
|
The 52-week high and low of Ajooni Biotech Ltd are Rs 6.60 and Rs 3.55 as of 20-Mar-2026.
Ajooni Biotech Ltd has a market capitalisation of ₹ 74 Cr as on 19-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Ajooni Biotech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹0.09
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.